Previous close | 3,448.00 |
Open | 3,469.00 |
Bid | 3,465.00 x 0 |
Ask | 3,466.00 x 0 |
Day's range | 3,439.00 - 3,488.00 |
52-week range | 2,431.00 - 3,531.00 |
Volume | |
Avg. volume | 399,486 |
Market cap | 6.476T |
Beta (5Y monthly) | 0.46 |
PE ratio (TTM) | 3,687.23 |
EPS (TTM) | 0.94 |
Earnings date | 25 Jul 2024 |
Forward dividend & yield | 0.59 (1.71%) |
Ex-dividend date | 02 May 2024 |
1y target est | N/A |
LexisNexis® Risk Solutions, a leading provider of data and analytics, today released its latest healthcare data brief highlighting new insights on key mental health trends including the continued increase in claims for mental health care, shifts in telehealth and in-person utilization, and specific diagnoses that have surged between 2019 and 2023.
LexisNexis® Risk Solutions earned recognition as a Category Leader in both the Transaction Screening and Adverse Media quadrants of the Watchlist and Adverse Media Monitoring Solutions, 2024: Market Update and Vendor Landscape report from Chartis Research.
Oliver thinks this growth stock could capitalise on the growing artificial intelligence revolution. However, he says the valuation could prove troubling. The post This growth stock could be positioned to capitalise on massive AI popularity appeared first on The Motley Fool UK.